Clinical trials monitoring service

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000017C
Awardee
Awarding agency
Obligated
$22,443,177

Award facts

Opportunity
Contract value 76% obligated
  • $22,443,177.42 Current, with exercised options
  • $29,637,086.61 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Princeton, NJ 08543, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00026 -$51,294
Funding Only Action P00025 -$228,689
Other Administrative Action 24 -$441,575
Other Administrative Action 23 -$2,272
Funding Only Action 22 $510,800
Funding Only Action 21 $700,312
Funding Only Action 20 $15,542
Exercise an Option 19 $2,132,000
Funding Only Action 18 $200,000
Funding Only Action 17 $19,181
Change Order 16 $345,128
Exercise an Option 15 $2,613,000
Change Order 14 $283,308
Exercise an Option 13 $87,364
Exercise an Option 12 $3,075,417
Other Administrative Action 11 $0
Change Order 10 $750,000
Change Order 9 $174,484
Exercise an Option 8 $2,966,467
Other Administrative Action 7 $0
Change Order 6 · Other functions clinical trials monitoring service $1,407,096
Other Administrative Action 5 $1,978,000
Funding Only Action 4 $1,394,318
Other Administrative Action 3 $0
Funding Only Action 2 $1,379,317
Change Order 1 $297,764
Original award $2,837,510
Show all 27

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a definitive contract to Theradex Systems, Inc. for clinical trials monitoring services on May 1, 2010, with a ceiling value of $29.6 million and ultimate completion date of April 30, 2017.

Work is performed in Princeton, NJ. The contract is priced on a cost-plus-fixed-fee basis with no set-aside category applied.

Quick answers

Who was awarded contract HHSN261201000017C?

HHSN261201000017C was awarded to Theradex Systems, Inc. by National Cancer Institute (National Institutes of Health) on May 1, 2010.

How much is contract HHSN261201000017C worth?

The government has obligated $22,443,177 on HHSN261201000017C. Its potential value, with all options, is $29,637,087.

Was contract HHSN261201000017C competed?

The extent of competition for HHSN261201000017C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login